The status of Pulmonary Arterial Hypertension in 2008

被引：28

作者：

Farber, Harrison W. ^{[1
]}

机构：

[1] Boston Univ, Sch Med, Pulm Hypertens Ctr, Boston, MA 02116 USA

来源：

CIRCULATION | 2008年 / 117卷 / 23期

关键词：

editorials; pulmonary heart disease; hypertension; pulmonary;

D O I：

10.1161/CIRCULATIONAHA.108.782979

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2966 / 2968

页数：3

共 12 条

[1] Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease [J].

Arcasoy, SM ;

Christie, JD ;

Ferrari, VA ;

Sutton, MS ;

Zisman, DA ;

Blumenthal, NP ;

Pochettino, A ;

Kotloff, RM .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (05) :735-740

[2] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[3] Beraprost therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

McLaughlin, V ;

Tapson, V ;

Oudiz, R ;

Shapiro, S ;

Robbins, IM ;

Channick, R ;

Badesch, D ;

Rayburn, BK ;

Flinchbaugh, R ;

Sigman, J ;

Arneson, C ;

Jeffs, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125

[4] Mechanisms of disease: Pulmonary arterial hypertension [J].

Farber, HW ;

Loscalzo, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (16) :1655-1665

[5] Ambrisentan for the treatment of pulmonary arterial hypertension -: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2 [J].

Galie, Nazzareno ;

Olschewski, Horst ;

Oudiz, Ronald J. ;

Torres, Fernando ;

Frost, Adaani ;

Ghofrani, Hossein A. ;

Badesch, David B. ;

McGoon, Michael D. ;

McLaughlin, Vallerie V. ;

Roecker, Ellen B. ;

Gerber, Michael J. ;

Dufton, Christopher ;

Wiens, Brian L. ;

Rubin, Lewis J. .

CIRCULATION, 2008, 117 (23) :3010-3019

[6] A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology [J].

Macchia, Alejandro ;

Marchioli, Roberto ;

Marfisi, RosaMaria ;

Scarano, Marco ;

Levantesi, Giacomo ;

Tavazzi, Luigi ;

Tognoni, Gianni .

AMERICAN HEART JOURNAL, 2007, 153 (06) :1037-1047

[7] Prognosis of pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines [J].

McLaughlin, VV ;

Presberg, KW ;

Doyle, RL ;

Abman, SH ;

McCrory, DC ;

Fortin, T ;

Ahearn, G .

CHEST, 2004, 126 (01) :78S-92S

[8] Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension [J].

Mereles, Derliz ;

Ehlken, Nicola ;

Kreuscher, Sandra ;

Ghofrani, Stefanie ;

Hoeper, Marius M. ;

Halank, Michael ;

Meyer, F. Joachim ;

Karger, Gabriele ;

Buss, Jan ;

Juenger, Jana ;

Holzapfel, Nicole ;

Opitz, Christian ;

Winkler, Joerg ;

Herth, Felix F. J. ;

Wilkens, Heinrike ;

Katus, Hugo A. ;

Olschewski, Horst ;

Gruenig, Ekkehard .

CIRCULATION, 2006, 114 (14) :1482-1489

[9] Narrative review: The enigma of pulmonary arterial hypertension: New insights from genetic studies [J].

Newman, John H. ;

Phillips, John A., III ;

Loyd, James E. .

ANNALS OF INTERNAL MEDICINE, 2008, 148 (04) :278-283

[10] The value of approved therapies for pulmonary arterial hypertension [J].

Rich, Stuart .

AMERICAN HEART JOURNAL, 2007, 153 (06) :889-890

← 1 2 →